These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23326087)

  • 1. Effect of a Polyherbal Unani formulation in acne vulgaris: A preliminary study.
    Lone AH; Habib S; Ahmad T; Anwar M
    J Ayurveda Integr Med; 2012 Oct; 3(4):180-3. PubMed ID: 23326087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of local application of an Unani formulation in acne vulgaris.
    Sultana S; Zulkifle M; Ansari AH; Shahnawaz
    Anc Sci Life; 2015; 35(2):124-8. PubMed ID: 26865747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy and safety of a pharmacopial polyherbal Unani formulation in pityriasis versicolor: a comparative randomized single-blind study.
    Lone AH; Ahmad T; Anwar M; Sofi G
    J Altern Complement Med; 2012 Oct; 18(10):978-82. PubMed ID: 22871048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The In vitro anti-acne activity of two unani drugs.
    Chaudhary SS; Tariq M; Zaman R; Imtiyaz S
    Anc Sci Life; 2013 Jul; 33(1):35-8. PubMed ID: 25161328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac) applied once daily and a clindamycin lotion formulation (Dalacin T) applied twice daily in the topical treatment of acne vulgaris.
    Zouboulis CC; Derumeaux L; Decroix J; Maciejewska-Udziela B; Cambazard F; Stuhlert A
    Br J Dermatol; 2000 Sep; 143(3):498-505. PubMed ID: 10971320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a twice-daily, 3-step, over-the-counter skincare regimen for the treatment of acne vulgaris.
    Rodan K; Fields K; Falla TJ
    Clin Cosmet Investig Dermatol; 2017; 10():3-9. PubMed ID: 28115862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of superficial chemical peeling in treatment of active acne vulgaris.
    Al-Talib H; Al-Khateeb A; Hameed A; Murugaiah C
    An Bras Dermatol; 2017; 92(2):212-216. PubMed ID: 28538881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile of acne vulgaris--a hospital-based study from South India.
    Adityan B; Thappa DM
    Indian J Dermatol Venereol Leprol; 2009; 75(3):272-8. PubMed ID: 19439880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation Between Stress Scale and Serum Substance P Level in Acne Vulgaris.
    Jusuf NK; Putra IB; Sutrisno AR
    Int J Gen Med; 2021; 14():681-686. PubMed ID: 33688239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on pathogenesis and treatment of acne.
    Lee DJ; Van Dyke GS; Kim J
    Curr Opin Pediatr; 2003 Aug; 15(4):405-10. PubMed ID: 12891054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acne analysis, grading and computational assessment methods: an overview.
    Ramli R; Malik AS; Hani AF; Jamil A
    Skin Res Technol; 2012 Feb; 18(1):1-14. PubMed ID: 21605170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for treating acne.
    Katsambas AD; Stefanaki C; Cunliffe WJ
    Clin Dermatol; 2004; 22(5):439-44. PubMed ID: 15556732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acne Vulgaris Mimicking Cutaneous Lupus Erythematosus in an Adolescent: Report of a Rare Case.
    Sitohang IBS; Rheza AM; Sirait SP; Fitri EM; Suseno LS
    Case Rep Dermatol; 2021; 13(1):69-74. PubMed ID: 33708086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.
    Richter JR; Förström LR; Kiistala UO; Jung EG
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):227-33. PubMed ID: 9883434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comprehensive Review of the Acne Grading Scale in 2023.
    Bae IH; Kwak JH; Na CH; Kim MS; Shin BS; Choi H
    Ann Dermatol; 2024 Apr; 36(2):65-73. PubMed ID: 38576244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective Intense Pulsed Light Protocol in the Treatment of Moderate to Severe Acne Vulgaris of the Chest and Back.
    Piccolo D; Kostaki D; Dianzani C; Crisman G; Conforti C
    J Clin Aesthet Dermatol; 2022 Mar; 15(3):22-25. PubMed ID: 35342499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of a nano-emulsion gel formulation of adapalene 0.1% and clindamycin 1% combination in acne vulgaris: a randomized, open label, active-controlled, multicentric, phase IV clinical trial.
    Prasad S; Mukhopadhyay A; Kubavat A; Kelkar A; Modi A; Swarnkar B; Bajaj B; Vedamurthy M; Sheikh S; Mittal R
    Indian J Dermatol Venereol Leprol; 2012; 78(4):459-67. PubMed ID: 22772617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
    Lucky AW; Henderson TA; Olson WH; Robisch DM; Lebwohl M; Swinyer LJ
    J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):746-54. PubMed ID: 9366821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Frequency Ultrasonography Evaluation of Acne by Thickness and Power Doppler Vascular Analysis.
    Wu X; Jiang T
    J Ultrasound Med; 2022 Oct; 41(10):2517-2525. PubMed ID: 35535957
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.